Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Alemtuzumab induction in renal transplantation.

Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J; INTAC Study Group.

N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546.

PMID:
21591943
[PubMed - indexed for MEDLINE]
Free Article
2.

Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.

Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF; Sirolimus High-Risk Study Group.

Transplantation. 2008 Nov 15;86(9):1187-95. doi: 10.1097/TP.0b013e318187bab0.

PMID:
19005398
[PubMed - indexed for MEDLINE]
3.

Strategies to increase living donor kidney transplants.

Barry JM, Conlin M, Golconda M, Norman D.

Urology. 2005 Nov;66(5 Suppl):43-6.

PMID:
16194706
[PubMed - indexed for MEDLINE]
4.

Factors associated with improvement in deceased donor renal allograft function in the 1990s.

Keith DS, DeMattos A, Golconda M, Prather J, Cantarovich M, Paraskevas S, Tchervenkov J, Norman DJ.

J Am Soc Nephrol. 2005 May;16(5):1512-21. Epub 2005 Mar 16.

PMID:
15772252
[PubMed - indexed for MEDLINE]
Free Article
5.

Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.

de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ.

Kidney Int. 2005 Feb;67(2):714-20.

PMID:
15673321
[PubMed - indexed for MEDLINE]
6.

Renal transplantation at Oregon Health and Science University: recent results and protocols.

Golconda MS, de Mattos AM, Prather J, Olyaei AJ, Fletcher L, Head MA, Wetzsteon P, Barry JM, Norman DJ.

Clin Transpl. 2003:149-54.

PMID:
15387106
[PubMed - indexed for MEDLINE]
7.

Effect of donor recipient age match on survival after first deceased donor renal transplantation.

Keith DS, Demattos A, Golconda M, Prather J, Norman D.

J Am Soc Nephrol. 2004 Apr;15(4):1086-91.

PMID:
15034113
[PubMed - indexed for MEDLINE]
Free Article
8.

Use of A(2) kidneys for B and O kidney transplant recipients: report of a series of patients transplanted at a single center spanning a decade.

Norman DJ, Prather JC, Alkhunaizi AM, deMattos AM, Golconda M, Barry JM.

Transplant Proc. 2001 Nov-Dec;33(7-8):3327-30. No abstract available.

PMID:
11750423
[PubMed - indexed for MEDLINE]
9.

Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients.

Golconda MS, Valente JF, Bejarano P, Gilinsky N, First MR.

Transplant Proc. 1999 Feb-Mar;31(1-2):272-3. No abstract available.

PMID:
10083104
[PubMed - indexed for MEDLINE]
10.

Economic costs of expanded criteria donors in renal transplantation.

Whiting JF, Golconda M, Smith R, O'Brien S, First MR, Alexander JW.

Transplantation. 1998 Jan 27;65(2):204-7.

PMID:
9458015
[PubMed - indexed for MEDLINE]
11.

Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience.

Golconda MS, Whiting JF, Smith R, Hayes R, Alexander JW, First MR.

Transplant Proc. 1997 Dec;29(8):3379-81. No abstract available.

PMID:
9414756
[PubMed - indexed for MEDLINE]
12.

Clinical and economic outcomes of expanded criteria donors in renal transplantation.

Whiting JF, Golconda M, Smith R, O'Brien S, First MR, Alexander JW.

Transplant Proc. 1997 Dec;29(8):3258.

PMID:
9414706
[PubMed - indexed for MEDLINE]
13.

1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient.

Golconda MS, Larson TS, Kolb LG, Kumar R.

Mayo Clin Proc. 1996 Jan;71(1):32-6. Review.

PMID:
8538229
[PubMed - indexed for MEDLINE]
14.

Evidence suggesting that iron and calcium are interrelated in oxidant-induced DNA damage.

Golconda MS, Ueda N, Shah SV.

Kidney Int. 1993 Dec;44(6):1228-34.

PMID:
8301924
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk